Asia
Japan—The Promise of an Aging Population
LBS Co.
Report
Despite the unconditional reduction in spending seen in the government and private sectors of Japan, Japanese independent public relations agencies remain cautiously optimistic about their pharmaceutical industry. “The hope is that aging populations in Japan, with a keen interest in maintaining youth and vigor, may carry the pharmaceutical industry through these difficult economic times,” says Homare Takenaka of the LBS Co., Ltd. firm in Japan.
Forecast
This aging population is not limited to Japan, of course. Many countries are now seeing the baby-boomer generation require more medicine and diagnostic tests. “That is why there is tremendous need and demand for global information and cooperation,” says Takenaka. If countries are able to embrace each other’s knowledge and innovations, the quality of care for this generation will be much higher and the pharmaceutical industry is much more likely to thrive.
